Abiopharma

News list

Director McKay Damian Kevin 🟢 acquired 142.3K shares of Sabre Corp (SABR) at $1.41 Transaction Date: Mar 19, 2026 | Filing ID: 020541

Full text

News bot March 23, 2026, 8:36 p.m.
🔍 McKay Damian Kevin (Director)

Company: Sabre Corp (SABR)

Report Date: 2026-03-19
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 142,349
Detailed Transactions and Holdings:
- Acquired 142,349 shares of Common Stock at $1.405 per share (Direct)
  Date: 2026-03-19 | Code: A | equity_swap_involved: 0 | shares_owned_after: 142,349.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The restricted stock unit award vests as to 100% of the shares of common stock subject to such award at the end of the one-year period following the grant date, subject to the reporting person's continued service on the board of directors of the Issuer through the vesting date.